1. Home
  2. MREO vs INDI Comparison

MREO vs INDI Comparison

Compare MREO & INDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • INDI
  • Stock Information
  • Founded
  • MREO 2015
  • INDI 2007
  • Country
  • MREO United Kingdom
  • INDI United States
  • Employees
  • MREO N/A
  • INDI N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • INDI Semiconductors
  • Sector
  • MREO Health Care
  • INDI Technology
  • Exchange
  • MREO Nasdaq
  • INDI Nasdaq
  • Market Cap
  • MREO 424.5M
  • INDI 471.6M
  • IPO Year
  • MREO N/A
  • INDI N/A
  • Fundamental
  • Price
  • MREO $2.85
  • INDI $3.17
  • Analyst Decision
  • MREO Strong Buy
  • INDI Strong Buy
  • Analyst Count
  • MREO 7
  • INDI 6
  • Target Price
  • MREO $7.71
  • INDI $5.75
  • AVG Volume (30 Days)
  • MREO 1.2M
  • INDI 4.0M
  • Earning Date
  • MREO 08-12-2025
  • INDI 08-07-2025
  • Dividend Yield
  • MREO N/A
  • INDI N/A
  • EPS Growth
  • MREO N/A
  • INDI N/A
  • EPS
  • MREO N/A
  • INDI N/A
  • Revenue
  • MREO N/A
  • INDI $218,406,000.00
  • Revenue This Year
  • MREO N/A
  • INDI $7.46
  • Revenue Next Year
  • MREO $54.07
  • INDI $32.80
  • P/E Ratio
  • MREO N/A
  • INDI N/A
  • Revenue Growth
  • MREO N/A
  • INDI N/A
  • 52 Week Low
  • MREO $1.58
  • INDI $1.53
  • 52 Week High
  • MREO $5.02
  • INDI $7.45
  • Technical
  • Relative Strength Index (RSI)
  • MREO 64.74
  • INDI 58.18
  • Support Level
  • MREO $2.61
  • INDI $3.13
  • Resistance Level
  • MREO $2.85
  • INDI $3.56
  • Average True Range (ATR)
  • MREO 0.17
  • INDI 0.25
  • MACD
  • MREO 0.03
  • INDI 0.01
  • Stochastic Oscillator
  • MREO 88.83
  • INDI 56.60

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for advanced Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.

Share on Social Networks: